| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |